Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis

被引:180
作者
Shimizu, Masaki [1 ]
Yokoyama, Tadafumi [1 ]
Yamada, Keiko [2 ]
Kaneda, Hisashi [3 ]
Wada, Hideo [4 ]
Wada, Taizo [1 ]
Toma, Tomoko [1 ]
Ohta, Kazuhide [5 ]
Kasahara, Yoshihito [1 ]
Yachie, Akihiro [1 ]
机构
[1] Kanazawa Univ, Dept Pediat, Sch Med, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9208641, Japan
[2] Tonami Gen Hosp, Dept Pediat, Tonami, Toyama, Japan
[3] Toyama City Hosp, Dept Pediat, Yoyama, Japan
[4] Noto Gen Hosp, Dept Pediat, Nanao, Japan
[5] Kanazawa Med Ctr, Dept Pediat, Kanazawa, Ishikawa, Japan
关键词
Macrophage activation syndrome; Systemic juvenile idiopathic arthritis; Interleukin-18; KILLER-CELL DYSFUNCTION; RHEUMATOID-ARTHRITIS; KAWASAKI-DISEASE; ADULT-ONSET; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; GAMMA PRODUCTION; STILLS-DISEASE; MARKER; DISORDERS; SEVERITY;
D O I
10.1093/rheumatology/keq133
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methods. Five patients with MAS complicating s-JIA (MAS/s-JIA), 10 with HLH due to EBV infection (EBV-HLH), 22 with KD and 28 healthy controls were analysed. Cytokine concentrations (IL-18, IL-6, neopterin and TNF-alpha receptor Types I and II) were quantified in serum by ELISA. Results were compared with clinical features of MAS/s-JIA, including ferritin concentrations. Results. Serum IL-18 concentrations in MAS/s-JIA patients were significantly higher than those in EBV-HLH or KD patients (P < 0.05). Serum IL-6 concentrations in KD patients were significantly higher than those in EBV-HLH or MAS/s-JIA patients. Serum neopterin concentrations in EBV-HLH patients were significantly higher than those in MAS/s-JIA or KD patients. Serum IL-18 correlated positively with the following measurements of disease activity: CRP, ferritin, lactate dehydrogenase and other cytokines (P < 0.05). Serum concentrations of IL-18 in s-JIA patients remained elevated in the inactive phase of disease, whereas clinical parameters and other cytokines normalized. Conclusions. IL-18 may be an important mediator in s-JIA. Although serum Il-18 concentrations correlated with markers of the disease activity, IL-18 concentrations remained elevated even when other markers of disease activity normalized. Serum IL-18 concentration may be a promising indicator of the disease activity. The cytokine release pattern in MAS/HLH is different among patients with different aetiologies. Monitoring the cytokine profile, including IL-18, may be useful for differentiation of MAS/HLH and evaluation of disease activity in s-JIA.
引用
收藏
页码:1645 / 1653
页数:9
相关论文
共 33 条
[11]   Natural killer cell dysfunction - A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? [J].
Grom, AA .
ARTHRITIS AND RHEUMATISM, 2004, 50 (03) :689-698
[12]   Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis [J].
Imashuku, S .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 44 (03) :259-272
[13]   Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis [J].
Jelusic, Marija ;
Lukic, Ivan Kresimir ;
Tambic-Bukovac, Lana ;
Dubravcic, Klara ;
Malcic, Ivan ;
Rudan, Igor ;
Batinic, Drago .
CLINICAL RHEUMATOLOGY, 2007, 26 (08) :1332-1334
[14]  
Kawaguchi Y, 2001, ARTHRITIS RHEUM, V44, P1716, DOI 10.1002/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO
[15]  
2-I
[16]  
Kawashima M., 2005, ARTHRITIS RHEUM, V52, P1794
[17]  
Lotito APN, 2007, J RHEUMATOL, V34, P823
[18]   Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al [J].
Maeno, N ;
Takei, S ;
Nomura, Y ;
Imanaka, H ;
Hokonohara, M ;
Miyata, K .
ARTHRITIS AND RHEUMATISM, 2002, 46 (09) :2539-2541
[19]   Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome? [J].
Muise, A ;
Tallett, SE ;
Silverman, ED .
PEDIATRICS, 2003, 112 (06) :E495-E497
[20]   Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association [J].
Newburger, JW ;
Takahashi, M ;
Gerber, MA ;
Gewitz, MH ;
Tani, LY ;
Burns, JC ;
Shulman, ST ;
Bolger, AF ;
Ferrieri, P ;
Baltimore, RS ;
Wilson, WR ;
Baddour, LM ;
Levison, ME ;
Pallasch, TJ ;
Falace, DA ;
Taubert, KA .
PEDIATRICS, 2004, 114 (06) :1708-1733